Skip to main content
. 2020 Jan 31;2020:1491475. doi: 10.1155/2020/1491475

Table 4.

PRRT therapeutic efficacy.

Modality Best response Frequency PFS (mean ± SD (months)) PFS (median (months))
PRRT alone CR 0/35 0%
PR 12/35 34% 28.0 ± 28.2 17
SD 19/35 54%
PD 3/35 9%
MR 1/35 3%

PRRT + SSA CR 0/30 0%
PR 16/30 53% 31.7 ± 18.1 27
SD 14/30 47%
PD 0/30 0%
MR 0/30 0%